MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Home・Lista de Ações・Cartesian Therapeutics Inc

Cartesian Therapeutics Inc

Fechado

8.95 -4.38

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

8.84

Máximo

9.09

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+346.17% upside

Cartesian Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de out. de 2025, 18:13 UTC

Grandes Movimentos do Mercado

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 de out. de 2025, 17:05 UTC

Grandes Movimentos do Mercado

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 de out. de 2025, 13:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 de out. de 2025, 08:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

18 de out. de 2025, 07:00 UTC

Ganhos

A Growing Nimby Movement Could Upend the Data Center Boom -- Barrons.com

17 de out. de 2025, 23:25 UTC

Aquisições, Fusões, Aquisições de Empresas

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 de out. de 2025, 22:15 UTC

Conversa de Mercado

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 de out. de 2025, 21:15 UTC

Conversa de Mercado

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 de out. de 2025, 21:07 UTC

Conversa de Mercado

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 de out. de 2025, 21:07 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

17 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de out. de 2025, 20:34 UTC

Conversa de Mercado

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 de out. de 2025, 20:27 UTC

Conversa de Mercado

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 de out. de 2025, 19:46 UTC

Conversa de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 de out. de 2025, 19:45 UTC

Conversa de Mercado

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 de out. de 2025, 18:45 UTC

Conversa de Mercado

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 de out. de 2025, 17:51 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de out. de 2025, 17:51 UTC

Conversa de Mercado

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 de out. de 2025, 17:44 UTC

Conversa de Mercado

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 de out. de 2025, 17:35 UTC

Conversa de Mercado

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 de out. de 2025, 16:20 UTC

Conversa de Mercado

Ganhos

Tech, Media & Telecom Roundup: Market Talk

17 de out. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de out. de 2025, 16:14 UTC

Conversa de Mercado

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 de out. de 2025, 16:04 UTC

Conversa de Mercado

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 de out. de 2025, 15:58 UTC

Conversa de Mercado

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 de out. de 2025, 15:56 UTC

Ganhos

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 de out. de 2025, 15:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

Comparação entre Pares

Variação de preço

Cartesian Therapeutics Inc Previsão

Preço-alvo

By TipRanks

346.17% parte superior

Previsão para 12 meses

Média 40.2 USD 346.17%

Máximo 42 USD

Mínimo 39 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Cartesian Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

Comprar

Manter

Vender

Com base em 7 analistas que deram avaliações de ações para Cartesian Therapeutics Inc - Dist nos últimos 3 meses.

Informação Financeira

Outras ações do setor

MDT

Medtronic PLC

95.62

↑ +0.66%

VEEV

Veeva Systems Inc

283

↓-3.27%

Agilent Technologies Inc

141.9

↑ +0.66%

HQY

HealthEquity Inc

91.19

↑ +0.35%

TLRY

Tilray Inc

1.55

↑ +1.31%

Cartesian Therapeutics Inc

Visão Geral

Variação de preço das ações

Recomendações

Cartesian Therapeutics Inc Gráfico

Notícias Relacionadas

Comparação entre Pares

Cartesian Therapeutics Inc Previsão

Preço-alvo

Consenso de Avaliação

Informação Financeira

Outras ações do setor